Literature DB >> 25691498

GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.

Carolina S Martinez1, Verónica G Piazza1, María E Díaz1, Ravneet K Boparai1, Oge Arum1, María C Ramírez1, Lorena González1, Damasia Becú-Villalobos1, Andrzej Bartke1, Daniel Turyn1, Johanna G Miquet1, Ana I Sotelo2.   

Abstract

GH/STAT5 signaling is desensitized in the liver in adult transgenic mice overexpressing GH; however, these animals present greater body size. To assess whether the STAT5 pathway is active during the growth period in the liver in these animals, and how signaling modulators participate in this process, growing transgenic mice and normal siblings were evaluated. STAT5 does not respond to an acute GH-stimulus, but displays higher basal phosphorylation in the livers of growing GH-overexpressing mice. GH receptor and the positive modulators glucocorticoid receptor and HNF1 display greater abundance in transgenic animals, supporting the activity of STAT5. The negative modulators cytokine-induced suppressor and PTP1B are increased in GH-overexpressing mice. The suppressors SOCS2 and SOCS3 exhibit higher mRNA levels in transgenic mice but lower protein content, indicating that they are being actively degraded. Therefore, STAT5 signaling is increased in the liver in GH-transgenic mice during the growth period, with a balance between positive and negative effectors resulting in accelerated but controlled growth.
© 2015 Society for Endocrinology.

Entities:  

Keywords:  GH signaling; GH-overexpressing mice; STAT5; growth; liver

Mesh:

Substances:

Year:  2015        PMID: 25691498      PMCID: PMC4811361          DOI: 10.1530/JME-14-0262

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  65 in total

Review 1.  The somatomedin hypothesis 2007: 50 years later.

Authors:  Solomon A Kaplan; Pinchas Cohen
Journal:  J Clin Endocrinol Metab       Date:  2007-11-06       Impact factor: 5.958

2.  Cytokine-inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice.

Authors:  L González; J G Miquet; A I Sotelo; A Bartke; D Turyn
Journal:  Endocrinology       Date:  2002-02       Impact factor: 4.736

3.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

Authors:  F Lupu; J D Terwilliger; K Lee; G V Segre; A Efstratiadis
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

4.  Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver.

Authors:  Yijing Zhang; Ekaterina V Laz; David J Waxman
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

5.  Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling.

Authors:  T E Adams; J A Hansen; R Starr; N A Nicola; D J Hilton; N Billestrup
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

Review 6.  The growth hormone receptor: mechanism of activation and clinical implications.

Authors:  Andrew J Brooks; Michael J Waters
Journal:  Nat Rev Endocrinol       Date:  2010-07-27       Impact factor: 43.330

7.  Multimeric growth hormone receptor complexes serve as signaling platforms.

Authors:  Magdalena Sedek; Lieke M van der Velden; Ger J Strous
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

Review 8.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

9.  Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.

Authors:  A I Sotelo; J G Miquet; L González; A Bartke; D Turyn
Journal:  Growth Horm IGF Res       Date:  2007-09-18       Impact factor: 2.372

10.  Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.

Authors:  Yong Fan; Ram K Menon; Pinchas Cohen; David Hwang; Thomas Clemens; Douglas J DiGirolamo; John J Kopchick; Derek Le Roith; Massimo Trucco; Mark A Sperling
Journal:  J Biol Chem       Date:  2009-05-21       Impact factor: 5.157

View more
  7 in total

1.  Bromodomain and Extraterminal Inhibition by JQ1 Produces Divergent Transcriptional Regulation of Suppressors of Cytokine Signaling Genes in Adipocytes.

Authors:  Paula Mota de Sá; Allison J Richard; Jacqueline M Stephens
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

Review 2.  Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.

Authors:  Shoshana Yakar; Olle Isaksson
Journal:  Growth Horm IGF Res       Date:  2015-09-28       Impact factor: 2.372

3.  Exposure to growth hormone is associated with hepatic up-regulation of cPLA2α and COX.

Authors:  Verónica G Piazza; María E Matzkin; Nadia S Cicconi; Nadia V Muia; Sofía Valquinta; Gregorio J Mccallum; Giannina P Micucci; Thomas Freund; Elsa Zotta; Lorena González; Mónica B Frungieri; Yimin Fang; Andrzej Bartke; Ana I Sotelo; Johanna G Miquet
Journal:  Mol Cell Endocrinol       Date:  2020-04-04       Impact factor: 4.102

4.  Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth period.

Authors:  Carolina S Martinez; Verónica G Piazza; Lorena González; Yimin Fang; Andrzej Bartke; Daniel Turyn; Johanna G Miquet; Ana I Sotelo
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

5.  Analysis of Different Approaches for the Selection of Reference Genes in RT-qPCR Experiments: A Case Study in Skeletal Muscle of Growing Mice.

Authors:  Verónica G Piazza; Andrzej Bartke; Johanna G Miquet; Ana I Sotelo
Journal:  Int J Mol Sci       Date:  2017-05-16       Impact factor: 5.923

6.  Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver.

Authors:  María L Bacigalupo; Verónica G Piazza; Nadia S Cicconi; Pablo Carabias; Andrzej Bartke; Yimin Fang; Ana I Sotelo; Gabriel A Rabinovich; María F Troncoso; Johanna G Miquet
Journal:  Endocr Connect       Date:  2019-08-01       Impact factor: 3.335

7.  Cerebral Insulin Bolus Revokes the Changes in Hepatic Lipid Metabolism Induced by Chronic Central Leptin Infusion.

Authors:  Vicente Barrios; Elena López-Villar; Laura M Frago; Sandra Canelles; Francisca Díaz-González; Emma Burgos-Ramos; Gema Frühbeck; Julie A Chowen; Jesús Argente
Journal:  Cells       Date:  2021-03-06       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.